Home>>Modified Nucleotides>>Pseudo-UTP,100mM Sodium Solution

Pseudo-UTP,100mM Sodium Solution (Synonyms: Pseudouridine-5'-Triphosphate, 5-Ribosyl Uracil)

Catalog No.GB20001

Pseudo-UTP is a modified UTP derived through base isomerization reaction and is often used for drug synthesis of mRNA.

Products are for research use only. Not for human use. We do not sell to patients.

Pseudo-UTP,100mM Sodium Solution Chemical Structure

Size Price Stock Qty
10ul
$40.00
In stock
50ul
$120.00
In stock
100ul
$180.00
In stock
1mL
$650.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Pseudo-UTP is derived from UTP through base isomerization reaction, which can perform complementary base pairing with adenosine like uridine, and change the structure of RNA by improving base pairing, base stacking and main chain stability [1]. The mRNA in which Pseudo-UTP completely replaces UTP exhibits lower immunogenicity, higher stability and translation ability [2].

References:
[1]. Yi-Tao Yu. RNA-guided isomerization of uridine to pseudouridine-pseudouridylation. Clin Chim Acta. 2014;11(12):1483-94. doi: 10.4161/15476286.2014.972855. PMCID: PMC4615163.
[2]. Muthian Shanmugasundaram, et al. An Efficient Protection-Free One-Pot Chemical Synthesis of Modified Nucleoside-5'-Triphosphates. Nucleosides Nucleotides Nucleic Acids. 2016 Jul 2;35(7):356-62.

Reviews

Review for Pseudo-UTP,100mM Sodium Solution

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pseudo-UTP,100mM Sodium Solution

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.